NASDAQ · Shell Companies · USD
Drugs Made In America Acquisition II Corp. (DMIIU) Stock Analysis
Drugs Made In America Acquisition II Corp. (DMIIU) is a Shell Companies stock listed on NASDAQ and quoted in US Dollar.
$10.20
$0.00 (0.00%)
Sep 4, 2026 · Market close
This is a derivative instrument — a unit issued alongside Drugs Made In America Acquisition II Corp. (DMII) common stock.
Issuer fundamentals are shown on the issuer page, not here.
View DMII →Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
DMIIU Key Statistics
As of Sep 4, 2026Trading
- Open
- $10.20
- Previous Close
- $10.20
- 52-Week Range
- 9.94–10.80
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
DMIIU Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +1.85% |
| 2025 (partial year) | +0.25% |
As of September 4, 2026.
Related Shell Companies Stocks
Churchill Capital Corp XI
$746.38M
CCCXChurchill Capital Corp X
$711.00M
DMIIDrugs Made In America Acquisition II Corp.
$647.83M
BCSSBain Capital GSS Investment Corp.
$602.40M
EVACEQV Ventures Acquisition Corp. II
$602.01M
CXIIChurchill Capital Corp XII
$594.94M
Popular Financial Services Stocks
Berkshire Hathaway Inc.
$1.08T
JPMJPMorgan Chase & Co.
$953.33B
VVisa Inc.
$700.27B
MAMastercard Incorporated
$507.39B
BACBank of America Corporation
$438.31B